Back to search

Article

WITHDRAWN: Identification of SUMOylation biomarkers in glioblastoma based on transcriptome and Mendelian randomization combined with single-cell RNA-seq analysis

2025-03-11

Abstract excerpt

<title>Abstract</title> <p>Aberrant SUMOylation has been associated with cancer, neurodegenerative diseases, and infections, but its exact role in glioblastoma (GBM) remains unknown. This study aimed to uncover this link and identify novel biomarkers for GBM treatment. NPC2, SPI1, and LRRC25 were identified as prognostic biomarkers for GBM outcomes. MR analysis showed that NPC2 and LRRC25 increased GBM risk, whil...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
29a82ada-626f-52a0-8e10-3fcc21d9148c
DOI
10.21203/rs.3.rs-6097394/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
WITHDRAWN: Identification of SUMOylation biomarkers in glioblastoma based on transcriptome and Mendelian randomization combined with single-cell RNA-seq analysisDOI 10.21203/rs.3.rs-6097394/v1
Select a neighboring publication to make it the new centre.